Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma

Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma

Abstract Importance 131I‐metaiodobenzylguanidine (131I‐mIBG) has a significant targeted antitumor effect for neuroblastoma. However, currently there is a paucity of data for the use of 131I‐mIBG as a “front‐line” therapeutic agent in those patients with newly diagnosed high‐risk neuroblastoma as par...

Full description

Bibliographic Details
Main Authors: Jianhua Feng, Frankie WT Cheng, Alex WK Leung, Vincent Lee, Eva WM Yeung, Hoi Ching Lam, Jeanny Cheung, Grace KS Lam, Terry TW Chow, Carol LS Yan, Chi Kong Li
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Pediatric Investigation
Subjects:
Neuroblastoma
131I‐mIBG
Transplantation
Online Access:https://doi.org/10.1002/ped4.12216

Internet

https://doi.org/10.1002/ped4.12216

Similar Items